319 related articles for article (PubMed ID: 24016806)
1. Vaccines against gonorrhea: current status and future challenges.
Jerse AE; Bash MC; Russell MW
Vaccine; 2014 Mar; 32(14):1579-87. PubMed ID: 24016806
[TBL] [Abstract][Full Text] [Related]
2. Vaccine research for gonococcal infections: where are we?
Jerse AE; Deal CD
Sex Transm Infect; 2013 Dec; 89 Suppl 4():iv63-8. PubMed ID: 24243883
[TBL] [Abstract][Full Text] [Related]
3. Diversion of the immune response to Neisseria gonorrhoeae from Th17 to Th1/Th2 by treatment with anti-transforming growth factor β antibody generates immunological memory and protective immunity.
Liu Y; Russell MW
mBio; 2011; 2(3):e00095-11. PubMed ID: 21610119
[TBL] [Abstract][Full Text] [Related]
4. Progress Toward a Gonococcal Vaccine: The Way Forward.
Russell MW; Jerse AE; Gray-Owen SD
Front Immunol; 2019; 10():2417. PubMed ID: 31681305
[TBL] [Abstract][Full Text] [Related]
5. The serogroup B meningococcal outer membrane vesicle-based vaccine 4CMenB induces cross-species protection against Neisseria gonorrhoeae.
Leduc I; Connolly KL; Begum A; Underwood K; Darnell S; Shafer WM; Balthazar JT; Macintyre AN; Sempowski GD; Duncan JA; Little MB; Rahman N; Garges EC; Jerse AE
PLoS Pathog; 2020 Dec; 16(12):e1008602. PubMed ID: 33290434
[TBL] [Abstract][Full Text] [Related]
6. Experimental vaccine induces Th1-driven immune responses and resistance to Neisseria gonorrhoeae infection in a murine model.
Liu Y; Hammer LA; Liu W; Hobbs MM; Zielke RA; Sikora AE; Jerse AE; Egilmez NK; Russell MW
Mucosal Immunol; 2017 Nov; 10(6):1594-1608. PubMed ID: 28272393
[TBL] [Abstract][Full Text] [Related]
7. Biological feasibility and importance of a gonorrhea vaccine for global public health.
Vincent LR; Jerse AE
Vaccine; 2019 Nov; 37(50):7419-7426. PubMed ID: 29680200
[TBL] [Abstract][Full Text] [Related]
8. Neisseria gonorrhoeae: Drug Resistance, Mouse Models, and Vaccine Development.
Rice PA; Shafer WM; Ram S; Jerse AE
Annu Rev Microbiol; 2017 Sep; 71():665-686. PubMed ID: 28886683
[TBL] [Abstract][Full Text] [Related]
9. Synthetic DNA Delivery of an Optimized and Engineered Monoclonal Antibody Provides Rapid and Prolonged Protection against Experimental Gonococcal Infection.
Parzych EM; Gulati S; Zheng B; Bah MA; Elliott STC; Chu JD; Nowak N; Reed GW; Beurskens FJ; Schuurman J; Rice PA; Weiner DB; Ram S
mBio; 2021 Mar; 12(2):. PubMed ID: 33727348
[TBL] [Abstract][Full Text] [Related]
10. Immune responses to
Belcher T; Rollier CS; Dold C; Ross JDC; MacLennan CA
Front Immunol; 2023; 14():1248613. PubMed ID: 37662926
[No Abstract] [Full Text] [Related]
11. Immunization against a saccharide epitope accelerates clearance of experimental gonococcal infection.
Gulati S; Zheng B; Reed GW; Su X; Cox AD; St Michael F; Stupak J; Lewis LA; Ram S; Rice PA
PLoS Pathog; 2013; 9(8):e1003559. PubMed ID: 24009500
[TBL] [Abstract][Full Text] [Related]
12. Female Mouse Model of Neisseria gonorrhoeae Infection.
Raterman EL; Jerse AE
Methods Mol Biol; 2019; 1997():413-429. PubMed ID: 31119637
[TBL] [Abstract][Full Text] [Related]
13. Is gonococcal disease preventable? The importance of understanding immunity and pathogenesis in vaccine development.
Edwards JL; Jennings MP; Apicella MA; Seib KL
Crit Rev Microbiol; 2016 Nov; 42(6):928-41. PubMed ID: 26805040
[TBL] [Abstract][Full Text] [Related]
14. Preclinical Efficacy of a Lipooligosaccharide Peptide Mimic Candidate Gonococcal Vaccine.
Gulati S; Pennington MW; Czerwinski A; Carter D; Zheng B; Nowak NA; DeOliveira RB; Shaughnessy J; Reed GW; Ram S; Rice PA
mBio; 2019 Nov; 10(6):. PubMed ID: 31690678
[TBL] [Abstract][Full Text] [Related]
15. Could vaccination against Neisseria gonorrhoeae be on the horizon?
Russell MW
Future Microbiol; 2018 Apr; 13():495-497. PubMed ID: 29517283
[No Abstract] [Full Text] [Related]
16. The Serogroup B Meningococcal Vaccine Bexsero Elicits Antibodies to Neisseria gonorrhoeae.
Semchenko EA; Tan A; Borrow R; Seib KL
Clin Infect Dis; 2019 Sep; 69(7):1101-1111. PubMed ID: 30551148
[TBL] [Abstract][Full Text] [Related]
17. Suppression of host adaptive immune responses by Neisseria gonorrhoeae: role of interleukin 10 and type 1 regulatory T cells.
Liu Y; Liu W; Russell MW
Mucosal Immunol; 2014 Jan; 7(1):165-76. PubMed ID: 23757303
[TBL] [Abstract][Full Text] [Related]
18. Neisseria gonorrhoeae vaccine development: hope on the horizon?
Edwards JL; Jennings MP; Seib KL
Curr Opin Infect Dis; 2018 Jun; 31(3):246-250. PubMed ID: 29601324
[TBL] [Abstract][Full Text] [Related]
19. Immunization with recombinant truncated Neisseria meningitidis-Macrophage Infectivity Potentiator (rT-Nm-MIP) protein induces murine antibodies that are cross-reactive and bactericidal for Neisseria gonorrhoeae.
Humbert MV; Christodoulides M
Vaccine; 2018 Jun; 36(27):3926-3936. PubMed ID: 29803329
[TBL] [Abstract][Full Text] [Related]
20. Common heat stable protective antigen in gonococci.
Ito JI; Corbeil LB; Wunderlich AC; McCutchan JA; Braude AI
Trans Assoc Am Physicians; 1979; 92():160-8. PubMed ID: 95067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
